Effect of PP in Patients With Ultra-low VT
Physiological Effect of Prone Position in Patients With Ultra-low Tidal Volume Ventilation
1 other identifier
observational
45
1 country
1
Brief Summary
Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome with similar clinicopathological feathers caused by different etiologies. Respiratory supportive strategies is the main ARDS management, and the guidelines recommend low tidal volume to improve clinical outcomes. To be note, overdistension can still occur even if using a tidal volume as low as 6 ml/kg, given the heterogeneous nature of the syndrome. Therefore, adjusting tidal volume level to less than 6ml/kg may reduce ventilator-induced lung injury (VILI) and thus improve outcomes, especially in patients with severe lung injury. Prone position is also an important management in severe ARDS. Prone position can improve ventilation-perfusion (V/Q) matching and reduce the risk of VILI by recruiting dorsal collapsed alveoli. Meanwhile, prone position has also been shown to improve hemodynamics. Recent studies have showed that prone position did not reduce duration of venovenous extracorporeal membrane oxygenation (VV-ECMO) and 90-day mortality in patients with ARDS who receive VV-ECMO with ultra-low tidal volume ventilation. Therefore, the effect of PP on ventilation and lung blood flow in ARDS patients treated with VV-ECMO wiht ultra-low tidal volume ventilation remains unclear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedStudy Start
First participant enrolled
February 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedApril 30, 2024
April 1, 2024
12 months
January 10, 2024
April 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
ventilation-perfusion mathching
ventilation-perfusion matching will be monitored using an EIT monitor (PulmoVista® 500, Dräger, Lübeck, Germany) in supine position and prone position
up to 24 hours
Secondary Outcomes (8)
The percentage of shunt
up to 24 hours
The percentage of dead space
up to 24 hours
The percentage of dorsal ventilation
up to 24 hours
The percentage of dorsal perfusion
up to 24 hours
Center of ventilation (CoV)
up to 24 hours
- +3 more secondary outcomes
Study Arms (1)
ultra-low tidal volume group
ARDS patients with ultra-low tidal volume ventilation
Interventions
Eligibility Criteria
Adult patients with ARDS admitted to the Department of Critical Care Medicine, Zhongda Hospital, Southeast University and receiving VV-ECMO treatment
You may qualify if:
- Adult patients were enrolled if they were undergoing invasive mechanical ventilation and were supported by VV-ECMO for less than 48 hours
You may not qualify if:
- younger than 18 years old
- contraindications for prone position ventilation
- past chronic respiratory diseases (long-term family oxygen therapy for chronic
- respiratory diseases such as pulmonary fibrosis or COPD)
- New York Heart Association class above II
- contraindications to the use of EIT (e.g., presence of pacemaker or chest surgical wounds dressing) or prone position (as decided by the attending physician)
- severe hemodynamic instability
- gave written or witnessed verbal informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University
Nanjing, Jiangsu, 210000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
liu ling, phD
Zhongda Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Intensive Care Unit, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
January 10, 2024
First Posted
January 22, 2024
Study Start
February 20, 2024
Primary Completion
February 1, 2025
Study Completion
April 1, 2025
Last Updated
April 30, 2024
Record last verified: 2024-04